Veröffentlichungen
Originalarbeiten, Bücher, Buchkapitel und Übersichtsartikel von Prof. Marcus Maurer
Verwendung: Beginnen Sie mit einer Übersicht über alle Publikationen. Verwenden Sie Tag-Links, um markierte Dokumente aufzulisten oder eine ganze Kategorie aufzulisten, z.B. Original Work (Originalarbeiten), Books (Bücher), Book Chapters (Buchkapitel), Reviews (Übersichtsartikel). Wenn Sie wissen, was Sie suchen, dann geben Sie diesen Begriff in das Suchfeld ein.
Omalizumab in chronic urticaria
| Filename | 61. Metz Maurer, Omalizumab in CU. COACI 2012.pdf |
| Filesize | 248,05 kB |
| Version | r.061 |
| Date added | Juni 26, 2020 |
| Downloaded | 0 times |
| Category | Reviews |
| Tags | anti-immunoglobulin (Ig) E, mast cell, physical urticaria, spontaneous urticaria, Xolair |
| Authors | Metz, M. and Maurer, M. |
| Citation | Metz, M. and Maurer, M.: Omalizumab in chronic urticaria. Curr. Opin. Allergy Clin. Immunol. 2012: 12; 406-411. |
| Corresponding authors | Maurer, M. |
| DocNum | R.61 |
| DocType | |
| Edition; Page | 12; 406-411 |
| IF | 3.39 |
| Publisher | Curr. Opin. Allergy Clin. Immunol. |
| ReleaseDate | 2012 |
Purpose of review: The current EAACI/GA2LEN/EDF/WAO treatment guidelines for the management of urticaria recommend omalizumab as fourth-line therapy. Within the last year, many reports of omalizumab treatment in chronic urticaria have been published.
Recent findings: Two multicenter, randomized, placebo-controlled trials in chronic spontaneous urticaria have shown excellent efficacy of omalizumab. Furthermore, in various case series and case reports, omalizumab has been shown to be effective also in inducible urticarias; however, no randomized placebo-controlled trial has been performed yet to thoroughly investigate the efficacy of omalizumab in inducible urticarias.
Summary: In this review, all published information on the use of omalizumab in urticaria will be summarized and discussed with special emphasis on reports published within the last year. The available data indicate that omalizumab is an effective and well tolerated drug in antihistamine-resistant chronic urticaria.
(Last update: 12.2023)
| Number of original publications in peer-reviewed journals: | 580 |
| Number of reviews in peer-reviewed journals: | 210 |
| Number of publications (original work and reviews) in peer-reviewed journals: | 790 |
| Cumulative IF for original publications in peer-reviewed journals: | 4196.39 |
| Cumulative IF for reviews in peer-reviewed journals: | 1409.32 |
| Cumulative IF of publications (original work & reviews) in peer-reviewed journals: | 5605.71 |
| Total number of citations: 36,836, h-index: 99 (Web of Science December 2023) | 36836 |
Download-Information
Um die angebotenen Veröffentlichungen herunterladen zu können, müssen Sie sich einloggen. Wenn Sie das Login nicht kennen, schreiben Sie mir bitte Ihre Anfrage.